Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Summary

Pelthos Therapeutics (NYSE American: PTHS) announced that CEO Scott Plesha will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 4, 2025 at 9:30 a.m. ET at The Lotte New York Palace, 455 Madison Avenue, New York.

Institutional investors can request in-person one-on-one meetings via their Piper Sandler representative. A live webcast of the fireside chat will be available on the company’s Investors News & Events page and posted at the event webcast link approximately two hours after the presentation.

DURHAM, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced that Pelthos’ CEO Scott Plesha will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference (the “Conference”) on December 4, 2025 at 9:30 a.m. Eastern Time at The Lotte New York Palace located at 455 Madison Avenue, New York, NY 10022.

Institutional investors interested in scheduling an in-person one-on-one meeting with Mr. Plesha should contact their Piper Sandler representative.

For those unable to attend the Conference in person, a live webcast of the fireside chat will be available on the News & Events page in the Investors section of the Company’s website at https://pelthos.com and can also be found at https://event.webcasts.com/starthere.jsp?ei=1745427&tp_key=593c737d0a approximately two hours after the fireside chat.

About Pelthos Therapeutics
Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens. The company’s lead product ZELSUVMI™ (berdazimer) topical gel, 10.3%, for the treatment of molluscum contagiosum, was approved by the U.S. Food and Drug Administration in 2024. More information is available at www.pelthos.com. Follow Pelthos on LinkedIn and X.

Contacts

Investors:
LifeSci Advisors, LLC
Mike Moyer, Managing Director
mmoyer@lifesciadvisors.com

Media:
KWM Communications
Kellie Walsh
pelthos@kwmcommunications.com
(914) 315-6072

FAQ

When will Pelthos Therapeutics (PTHS) present at the Piper Sandler 2025 conference?

Pelthos CEO Scott Plesha will present on December 4, 2025 at 9:30 a.m. ET.

How can investors attend Pelthos Therapeutics (PTHS) fireside chat in person?

Institutional investors should contact their Piper Sandler representative to request a one-on-one meeting.

Where will Pelthos Therapeutics (PTHS) hold its Piper Sandler 2025 presentation?

The presentation is at The Lotte New York Palace, 455 Madison Avenue, New York, NY.

Will Pelthos Therapeutics (PTHS) provide a webcast of the Piper Sandler fireside chat?

Yes. A live webcast will be available on the company’s Investors News & Events page and posted to the event webcast link about two hours after the chat.

Where can I find the Pelthos (PTHS) webcast link for the Piper Sandler presentation?

The webcast will be available on https://pelthos.com under News & Events and at the event webcast URL provided by the conference.